Winway Health Desk
Alignment Healthcare aims to raise up to $516M in IPO
Insurtech startup Alignment Healthcare has launched its much-anticipated IPO, through which it aims to raise between $462 million and $516 million.
The Orange, California-based startup...
Gene therapy developer XyloCor adds $22.6M to expand clinical trial plans
XyloCor Therapeutics, a clinical-stage company developing a gene therapy for a form of heart disease, has raised $22.6 million to expand the clinical trial...
Health analytics startup Komodo passes $3.3B valuation
More investors are pouring funds into Komodo Health, a healthcare analytics startup working to follow patient encounters and outcomes using de-identified data. The company...
Roche’s Tecentriq is the first I-O drug to claim a post-surgery...
Industry watchers have pegged PD-1/L1 cancer immunotherapies’ next phase of growth on their potential in the pre- and post-surgery settings. And Roche has claimed the...
Pharma sales face multiple question marks in 2021, thanks to the...
Pharma companies always worry about pricing and regulatory issues, but the pandemic added another layer of what-ifs last year.
From skyrocketing expenses and delayed drug approvals...
WuXi Bio, busy building out ex-China production network, taps local CDMO...
WuXi Biologics marked 2020 with gung-ho expansions as the China-based CDMO looked to beef up its operations in Europe and the U.S. Now, the company is turning...
Hospitals to DOJ: UnitedHealth’s purchase of Change Healthcare will curtail competition
A multibillion-dollar acquisition involving an insurance giant and health technology company has the country’s most prominent hospital group very concerned.
The American Hospital Association...
FTC’s crackdown on pharma mergers reflects ‘tougher’ M&A environment under Biden...
A flood of biopharma M&A in recent years has prompted the Biden administration’s Federal Trade Commission to take another look at how the industry’s...
AstraZeneca’s Covid-19 vaccine is 79% effective; FDA submission on the way
The AstraZeneca Covid-19 vaccine that is now cleared for use in more than 70 countries now has the pivotal clinical trial data that could...
AstraZeneca preps COVID-19 vaccine for FDA filing armed with 79% efficacy...
With the U.S. vaccinating millions of people per day and racing against new COVID-19 variants, a fourth shot looks to be on its way....
